10x Genomics provides instruments, consumables and software that let researchers analyze biology at single-cell and spatial resolution. Its Chromium, Visium and Xenium platforms are widely used in academic labs, biopharma and clinical research to map gene expression cell by cell or within tissue context. The company sells an integrated workflow of reagents and analysis tools rather than therapeutic drugs.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 172.9 | — | 34.5 | — |
| Q3 2025 | 149 | — | -27.5 | — |
| Q4 2025 | 166 | — | -16.3 | — |
| Q1 2026 | 150.8 | — | -13.5 | — |
| Q2 2026 | 151 | -12.7% | -17.9 | -151.9% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Sirius XM Holdings Inc. (SIRI), Cognex Corporation (CGNX), Liberty Live Holdings, Inc. (LLYVK), Saia, Inc. (SAIA), Tetra Tech, Inc. (TTEK), Vicor Corporation (VICR)